Angiogenesis and non-small cell lung cancer

被引：95
作者：
Cox, G
Jones, JL
Walker, RA
Steward, WP
O'Byrne, KJ
机构：
[1] Leicester Royal Infirm, Univ Dept Med Oncol, Leicester LE1 5WW, Leics, England
[2] Glenfield Gen Hosp, Dept Resp Med, Leicester LE3 9QP, Leics, England
[3] Glenfield Gen Hosp, Dept Pathol, Leicester LE3 9QP, Leics, England
来源：
LUNG CANCER | 2000年 / 27卷 / 02期
关键词：
angiogenesis; matrix metalloproteinases; growth factors; apoptosis; non-small cell lung cancer;
D O I：
10.1016/S0169-5002(99)00096-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Lung cancer is the commonest cause of cancer death in the western world. Recent evidence suggests that angiogenesis is related to poor prognosis in many solid tumours including non-small cell lung cancer. Angiogenesis is controlled by a complex interaction between growth and apoptotic factors, proteases and adhesion molecules. The angiogenic process may prove a target for novel therapies such as matrix metalloproteinase inhibitors, growth factor antisense RNA, growth factor. receptor antagonists and naturally occurring antiangiogenic peptides. These agents may be used alone ol in combination with traditional chemotherapy, radiotherapy and surgery. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：81 / 100
页数：20
相关论文
共 270 条
[21]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[22]   Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693
[23]  
BROWN LF, 1993, AM J PATHOL, V143, P1255
[24]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN BREAST-CANCER [J].
BROWN, LF ;
BERSE, B ;
JACKMAN, RW ;
TOGNAZZI, K ;
GUIDI, AJ ;
DVORAK, HF ;
SENGER, DR ;
CONNOLLY, JL ;
SCHNITT, SJ .
HUMAN PATHOLOGY, 1995, 26 (01) :86-91
[25]  
BROWN LF, 1993, CANCER RES, V53, P4727
[26]   ASSOCIATION BETWEEN EXPRESSION OF ACTIVATED 72-KILODALTON GELATINASE AND TUMOR SPREAD IN NON-SMALL-CELL LUNG-CARCINOMA [J].
BROWN, PD ;
BLOXIDGE, RE ;
STUART, NSA ;
GATTER, KC ;
CARMICHAEL, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (07) :574-578
[27]   Breast lesions: Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis [J].
Buadu, LD ;
Murakami, J ;
Murayama, S ;
Hashiguchi, N ;
Sakai, S ;
Masuda, K ;
Toyoshima, S ;
Kuroki, S ;
Ohno, S .
RADIOLOGY, 1996, 200 (03) :639-649
[28]   GROWTH-FACTOR MODULATION OF P53-MEDIATED GROWTH ARREST VERSUS APOPTOSIS [J].
CANMAN, CE ;
GILMER, TM ;
COUTTS, SB ;
KASTAN, MB .
GENES & DEVELOPMENT, 1995, 9 (05) :600-611
[29]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[30]   Relationship between vascularity, age and survival in non small-cell lung cancer [J].
Chandrachud, LM ;
Pendleton, N ;
Chisholm, DM ;
Horan, MA ;
Schor, AM .
BRITISH JOURNAL OF CANCER, 1997, 76 (10) :1367-1375
12345678910